Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triptorelin 6-month depot in advanced or metastatic prostate cancer (China)
CTR20221796Phase 3Completed
- Sponsor
- Ipsen
- Start
- Jul 2022
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of triptorelin in prostate cancer (PCa), sponsored by Ipsen. Started Jul 2022; status: completed.
02
Drugs
triptorelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on CTR20221796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221796.